IT1317885B1 - Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia. - Google Patents

Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.

Info

Publication number
IT1317885B1
IT1317885B1 IT2000RM000433A ITRM20000433A IT1317885B1 IT 1317885 B1 IT1317885 B1 IT 1317885B1 IT 2000RM000433 A IT2000RM000433 A IT 2000RM000433A IT RM20000433 A ITRM20000433 A IT RM20000433A IT 1317885 B1 IT1317885 B1 IT 1317885B1
Authority
IT
Italy
Prior art keywords
fibrates
preparation
treatment
congestial
useful drug
Prior art date
Application number
IT2000RM000433A
Other languages
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM20000433A0 publication Critical patent/ITRM20000433A0/it
Priority to IT2000RM000433A priority Critical patent/IT1317885B1/it
Priority to DE60120985T priority patent/DE60120985T2/de
Priority to KR1020037000135A priority patent/KR100844190B1/ko
Priority to PCT/IT2001/000390 priority patent/WO2002009682A2/en
Priority to BR0112874-4A priority patent/BR0112874A/pt
Priority to AT01955528T priority patent/ATE330597T1/de
Priority to CA002415042A priority patent/CA2415042C/en
Priority to US10/343,626 priority patent/US20030176499A1/en
Priority to EP01955528A priority patent/EP1305020B1/en
Priority to PL01365040A priority patent/PL365040A1/xx
Priority to CNA018131425A priority patent/CN1798554A/zh
Priority to JP2002515235A priority patent/JP2004505037A/ja
Priority to ES01955528T priority patent/ES2267796T3/es
Priority to PT01955528T priority patent/PT1305020E/pt
Priority to SI200130574T priority patent/SI1305020T1/sl
Priority to AU7768601A priority patent/AU7768601A/xx
Priority to AU2001277686A priority patent/AU2001277686B2/en
Priority to MXPA03000900A priority patent/MXPA03000900A/es
Priority to SK131-2003A priority patent/SK287410B6/sk
Publication of ITRM20000433A1 publication Critical patent/ITRM20000433A1/it
Application granted granted Critical
Publication of IT1317885B1 publication Critical patent/IT1317885B1/it
Priority to CY20061100936T priority patent/CY1106318T1/el
Priority to US12/453,470 priority patent/US20090221701A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT2000RM000433A 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia. IT1317885B1 (it)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
CNA018131425A CN1798554A (zh) 2000-08-01 2001-07-20 贝特类在制备用于治疗充血性心力衰竭的药物中的用途
ES01955528T ES2267796T3 (es) 2000-08-01 2001-07-20 Uso de fibratos para la preparacion de un medicamento util en el tratamiento de insuficiencia cardiaca congestiva.
PCT/IT2001/000390 WO2002009682A2 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
BR0112874-4A BR0112874A (pt) 2000-08-01 2001-07-20 Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva
AT01955528T ATE330597T1 (de) 2000-08-01 2001-07-20 Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens
CA002415042A CA2415042C (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
US10/343,626 US20030176499A1 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
EP01955528A EP1305020B1 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
PL01365040A PL365040A1 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
DE60120985T DE60120985T2 (de) 2000-08-01 2001-07-20 Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens
JP2002515235A JP2004505037A (ja) 2000-08-01 2001-07-20 鬱血性心不全の治療に有用な薬剤の調製のためのフィブレートの使用
KR1020037000135A KR100844190B1 (ko) 2000-08-01 2001-07-20 울혈성 심부전의 치료에 유용한 약제의 제조를 위한피브레이트의 용도
PT01955528T PT1305020E (pt) 2000-08-01 2001-07-20 Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva
SI200130574T SI1305020T1 (sl) 2000-08-01 2001-07-20 Uporaba fibratov za izdelavo zdravila za zdravljenje kongestivne srcne odpovedi
AU7768601A AU7768601A (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
AU2001277686A AU2001277686B2 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
MXPA03000900A MXPA03000900A (es) 2000-08-01 2001-07-20 Uso de fibratos para la preparacion de un medicamento util en el tratamiento de la insuficiencia cardiaca congestiva.
SK131-2003A SK287410B6 (sk) 2000-08-01 2001-07-20 Použitie fibrátov na prípravu lieku
CY20061100936T CY1106318T1 (el) 2000-08-01 2006-07-06 Χρηση ινωδων για την παρασκευη ενος φαρμακου χρησιμου στην θepαπεια της συμφορητικης καρδιακης ανεπαρκειας
US12/453,470 US20090221701A1 (en) 2000-08-01 2009-05-12 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.

Publications (3)

Publication Number Publication Date
ITRM20000433A0 ITRM20000433A0 (it) 2000-08-01
ITRM20000433A1 ITRM20000433A1 (it) 2002-02-01
IT1317885B1 true IT1317885B1 (it) 2003-07-15

Family

ID=11454866

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.

Country Status (18)

Country Link
US (2) US20030176499A1 (it)
EP (1) EP1305020B1 (it)
JP (1) JP2004505037A (it)
KR (1) KR100844190B1 (it)
CN (1) CN1798554A (it)
AT (1) ATE330597T1 (it)
AU (2) AU2001277686B2 (it)
BR (1) BR0112874A (it)
CA (1) CA2415042C (it)
CY (1) CY1106318T1 (it)
DE (1) DE60120985T2 (it)
ES (1) ES2267796T3 (it)
IT (1) IT1317885B1 (it)
MX (1) MXPA03000900A (it)
PL (1) PL365040A1 (it)
PT (1) PT1305020E (it)
SK (1) SK287410B6 (it)
WO (1) WO2002009682A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208238A1 (en) * 2002-03-11 2003-09-22 TAYLOR, , Carla Use of ppar alpha agonists for the treatment of vascular and renal diseases
CN100347262C (zh) * 2003-11-13 2007-11-07 同济大学 一种水溶性建筑粘结剂及其制备方法
JP5317919B2 (ja) * 2009-10-05 2013-10-16 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208203A1 (es) * 1974-09-10 1976-12-09 Cortial Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
EP0930882A2 (en) * 1996-08-02 1999-07-28 Institut Pasteur De Lille Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
WO1999005331A1 (en) * 1997-07-22 1999-02-04 Olin Corporation Copper alloy having magnesium addition
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0002667D0 (en) * 2000-02-04 2000-03-29 Glaxo Group Ltd medicamesnts
US7352911B2 (en) * 2003-07-31 2008-04-01 Hewlett-Packard Development Company, L.P. Method for bilateral filtering of digital images

Also Published As

Publication number Publication date
US20030176499A1 (en) 2003-09-18
AU7768601A (en) 2002-02-13
PT1305020E (pt) 2006-10-31
CA2415042A1 (en) 2002-02-07
KR20030041953A (ko) 2003-05-27
MXPA03000900A (es) 2003-10-06
CA2415042C (en) 2009-06-23
EP1305020A2 (en) 2003-05-02
DE60120985D1 (de) 2006-08-03
US20090221701A1 (en) 2009-09-03
ITRM20000433A1 (it) 2002-02-01
KR100844190B1 (ko) 2008-07-04
ATE330597T1 (de) 2006-07-15
SK1312003A3 (en) 2003-06-03
SK287410B6 (sk) 2010-09-07
AU2001277686B2 (en) 2006-07-20
CN1798554A (zh) 2006-07-05
CY1106318T1 (el) 2011-10-12
WO2002009682A2 (en) 2002-02-07
BR0112874A (pt) 2003-07-01
EP1305020B1 (en) 2006-06-21
WO2002009682A3 (en) 2002-04-18
ITRM20000433A0 (it) 2000-08-01
ES2267796T3 (es) 2007-03-16
DE60120985T2 (de) 2006-12-21
PL365040A1 (en) 2004-12-27
JP2004505037A (ja) 2004-02-19

Similar Documents

Publication Publication Date Title
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
SE0001899D0 (sv) New compounds
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
CY1111498T1 (el) Ελαχιστοποιηση της δυσμενους εμπειριας που συνδεεται με τη θεραπεια οξυβουτινινης
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
MY121517A (en) Anticonvulsant derivatives useful in reducing blood glucose levels
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
CY1109001T1 (el) Οι καππα-οπιοιδεις αγωνιστες στη θεραπεια των παθησεων της κυστης
SE0102440D0 (sv) New compound
DE60128100D1 (de) Analgetisches arzneimittel
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
IT1317885B1 (it) Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
DE60006788D1 (de) Iod-herstellungszusammensetzung
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ES2191206T3 (es) Nueva utilizacion de la creatina.
ES2177769T3 (es) Derivado de aminotetralina para la terapia de trastornos cardiovascu lares.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ITTO20020582A1 (it) Nuovo uso della rapamicina e di suoi analoghi strutturali
ES2122387T3 (es) Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
IT1306184B1 (it) Nitrilossi derivati della (r) e (s)-carnitina.